2021 European guideline on HIV testing in genito-urinary medicine settings.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
21
10
2020
accepted:
14
01
2021
pubmed:
6
3
2021
medline:
15
5
2021
entrez:
5
3
2021
Statut:
ppublish
Résumé
Testing for HIV is critical for early diagnosis of HIV infection, providing long-term good health for the individual and prevention of onward transmission if antiretroviral treatment is initiated early. The main purpose of the 2021 European Guideline on HIV Testing in Genito-Urinary Settings is to provide advice on testing for HIV infection in individuals aged 16 years and older who present to sexually transmitted infection, genito-urinary or dermato-venereology clinics across Europe. The guideline presents the details of best practice and offers practical guidance to clinicians and laboratories to identify and offer HIV testing to appropriate patient groups.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1043-1057Informations de copyright
© 2021 European Academy of Dermatology and Venereology.
Références
Joint United Nations Programme on HIV/AIDS. 90-90-90 An Ambitious Target to Help End the AIDS epidemic. Geneva: UNAIDS; 2014. URL https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf (last accessed: 8 October 2020).
European Centre for Disease Prevention and Control. Continuum of HIV Care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2018 Progress Report. Stockholm: ECDC, 2018. URL https://www.ecdc.europa.eu/en/publications-data/continuum-hiv-care-monitoring-implementation-dublin-declaration-2018-progress (last accessed: 8 October 2020).
Brown AE, Hayes R, Noori T et al. HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Eurosurveill 2018; 23: 1800622. https://doi.org/10.2807/1560-7917.ES.2018.23.48.1800622
European Centre for Disease Prevention and Control. Continuum of HIV care. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report. Stockholm: ECDC; 2018. https://www.ecdc.europa.eu/sites/default/files/documents/HIV-testing-dublin-declaration-monitoring-2018.pdf (last accessed: 8 October 2020).
European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2019-2018 data. Stockholm: ECDC; 2019. URL https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2019-2018-data (last accessed: 8 October 2020).
Gökengin D, Geretti AM, Begovac J et al. 2014 European guideline on HIV testing. Int J STD AIDS 2014; 25: 695-704.
British HIVAssociation/British Association for Sexual Health and HIV/British Infection AssociationAdult HIV Testing Guidelines 2020. https://www.bhiva.org/file/5f68c0dd7aefb/HIV-testing-guidelines-2020.pdf (last accessed: 8 October 2020).
Branson BM, Handsfield HH, Lampe MA et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55(RR-14): 1-17; quiz CE1-4.
Centers for Disease Control and Prevention. 2018 Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens; 2018. URL https://stacks.cdc.gov/view/cdc/50872 (last accessed: 8 October 2020).
US Preventive Services Task Force. Screening for HIV infection: US preventive services task force recommendation statement. JAMA 2019; 321: 2326-2336.
HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. HIV in Europe. URL http://www.eurotest.org/Portals/0/Guidance.pdf.pdf (last accessed: 8 October 2019).
UNAIDS and World Health Organization (WHO) Working Group on Global HIV/AIDS/STI Surveillance Guidelines for Using HIV Testing Technologies in Surveillance: Selection, Evaluation, and Implementation, 2009. URL https://www.who.int/hiv/pub/surveillance/hiv_testing_technologies_surveillance.pdf (last accessed: 8 October 2020).
WHO Guidance on Provider-initiated HIV Testing and Counseling in Health Facilities, 2007. https://apps.who.int/iris/bitstream/handle/10665/43688/9789241595568_eng.pdf;jsessionid=095254E39AE8A8ABC70C3B36DA7771DD?sequence=1 (last accessed: 8 October 2019).
European Centre for Disease Prevention and Control. Public Health Guidance: HBV, HCV and HIV Testing in the EU/EEA: An Integrated Approach. Stockholm: ECDC, 2018. URL https://www.ecdc.europa.eu/sites/default/files/documents/hiv-hep-testing-guidance_0.pdf (accessed October 8th, 2019).
Kitahata MM, Gange SJ, Abraham AG et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-1826.
May M, Gompels M, Delpech V et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343: d6016.
Johnson LF, Nakagawa F, May M et al. Updates of lifetime costs of care and quality of life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr 2013; 64: 183-189.
May M, Gompels M, Sabin C. Life expectancy of HIV-1-positive individuals approaches normal, conditional on response to antiretroviral therapy: UK collaborative HIV cohort study. J Int AIDS Soc 2012; 15(Suppl 4): 18078.
Soria A, Lazzarin A. Antiretroviral treatment strategies and immune reconstitution in treatment-naive HIVinfected patients with advanced disease. J Acquir Immune Defic Syndr 2007; 46: 19-30.
The INSIGHT START Study. Group initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015; 373: 795-807.
Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
Rodger AJ, Cambiano V, Bruun T et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316: 171-181.
Bavinton BR, Pinto AN, Phanuphak N et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV 2018; 5: 438-447.
Rodger AJ, Cambiano V, Bruun T et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 393: 2428-2438.
Desenclos JC, Papaevangelou G, Ancelle PR. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. AIDS 1993; 7: 1371-1377.
Kamb ML, Fishbein M, Douglas JM, Jr et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998; 280: 1161-1167.
Gibson DR, Lovelle-Drache J, Young M et al. Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users: final results of randomized trials of counseling with and without HIV testing. AIDS Behav 1999; 3: 3-12.
Allen S, Meinzen-Derr J, Kautzman M et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 2003; 17: 733-740.
Crepaz N, Lyles CM, Wolitski RJ et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006; 20: 143-157.
Marks G, Crepaz N, Senterfitt JW et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications of HIV prevention programs. J Acquire Immune Defic Syndr 2005; 39: 446-453.
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447-1450.
Gamoudi D, Flew S, Cusini M et al. 2018 European guideline on the organization of a consultation for sexually transmitted infections. J Eur Acad Dermatol Venereol 2019; 33: 1452-1458.
Rayment M, Thornton A, Mandalia S et al. HIV testing in non-traditional settings-the HINTS study: a multicentre observational study of feasibility and acceptability. PLoS One 2012; 7: e39530.
Vanhems P, Allard R, Cooper DA, Perrin L, Vizzard J, Hirschel B et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24: 965-970.
Sullivan AK, Raben D, Reekie J et al. Feasibility and effectiveness of indicator condition guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS One 2013; 8: e52845.
Raben D, Mocroft A, Rayment M et al. Auditing HIV testing rates across Europe: results from the HIDES 2 study. PLoS One 2015; 10: e0140845.
Menacho I, Sequeira E, Muns M et al. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions. HIV Med 2013; 14: 33-37.
Davies C, May M, Gompels M. Use and effectiveness of HIV indicator conditions in guiding HIV testing: a review of the evidence. Int STD Res Rev 2017; 6: 36373.
Dalal S, Johnson C, Fonner V et al. Improving HIV test uptake and case finding with assisted partner notification services. AIDS 2017; 31: 1867-1876.
Likatavičius G, Klavs I, Devaux I et al. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: implications for a European public health strategy. Sex Transm Inf 2008; 84: 499-505.
Ferrer L, Furegato M, Foschia JP et al. Undiagnosed HIV infection in a population of MSM from six European cities: results from the Sialon Project. Eur J Public Health 2015; 25: 494-500.
Baral S, Poteat T, Wirtz A et al. Global burden of HIV infection among transgender persons: a systematic review and meta-analysis. J Int AIDS Soc 2012; 15: 98-99.
Poteat T, Scheim A, Xavier J et al. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016; 72(Suppl 3): S210-S219.
Mathers BM, Degenhardt L, Phillips B et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-1745.
Degenhardt L, Peacock A, Colledge S et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 2017; 5: e1192-e1207.
Data on the size of the HIV/AIDS epidemic: prevalence of HIV among adults aged 15 to 49 (%) by country. WHO, 2019. http://apps.who.int/gho/data/view.main.22100WHO?lang=en (last accessed: 8 October 2019).
Joore IK, Arts DL, Kruijer MJP et al. HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care. Sex Transm Infect 2015; 91: 467-472.
Graves N, Walker DG, McDonald AM et al. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Infect Dis 2004; 190: 166-174.
Seña AC, Hsu KK, Kellogg N, Girardet R, Christian CW, Linden J et al. Sexual assault and sexually transmitted infections in adults, adolescents, and children. Clin Infect Dis 2015; 15(61 Suppl 8): S856-S864.
Paltiel AD, Weinstein MC, Kimmel AD et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586-595.
Chou R, Dana T, Grusing S et al. Screening for HIV infection in asymptomatic, nonpregnant adolescents and adults. Updated evidence report and systematic review for the US Preventive ServicesTask Force. Evidence Synthesis, No. 176. Report No: 18-05246-EF-1.
Balaji AB, Bowles KE, Le BC et al. NHBS Study Group. High HIV incidence and prevalence and associated factors among young MSM. AIDS 2013; 27: 269-278.
HIV testing among men who have sex with men: 21 cities, United States, 2008. Morb Mortal Wkly Rep 2011; 60: 694-699.
Owens DK, Davidson KW, Krist AH et al. Screening for HIV infection: US preventive services task force recommendation statement. JAMA 2019; 321: 2326-2336.
Delivering HIV test results and messages for retesting and counselling in adults. WHO, 2014. URL https://apps.who.int/iris/bitstream/handle/10665/44278/9789241599115_eng.pdf?sequence=1 (last accessed: 20 January 2020).
Vriend HJ, Stolte IG, Heijne JC et al. Repeated STI and HIV testing among HIV-negative men who have sex with men attending a large STI clinic in Amsterdam: a longitudinal study. Sex Transm Infect 2015; 91: 294-299.
Hutchinson AB, Farnham PG, Sansom SL et al. Cost-effectiveness of frequent HIV testing of high-risk populations in the United States. J Acquir Immune Defic Syndr 2016; 71: 323-330.
Di Nenno EA, Prejean J, Irwin K et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men-United States, 2017. Morb Mortal Wkly Rep 2017; 66: 830-832.
Hutchinson AB, Hicks KA, Yaylali E et al. Cost-Effectiveness of HIV Screening of Heterosexuals in the United States. Conference on Retroviruses and Opportunistic Infections. March 8-11, 2020 Boston, MA. Abstract number 1029. URL http://www.croiconference.org/sessions/cost-effectiveness-hiv-screening-heterosexuals-united-states (last accessed: 20 January 2020).
Mabileau G, Amo JD, Rüütel K et al. Effectiveness and cost-effectiveness of HIV screening strategies across Europe. Conference on Retroviruses and Opportunistic Infections. March 8-11, 2020 Boston, MA. Abstract number 1028. URL http://www.croiconference.org/sites/default/files/posters-2017/1028_Mabileau.pdf (last accessed: 20 January 2019).
Epstein RM, Morse DS, Frankel RM et al. Awkward moments in patient-physician communication about HIV risk. Ann Intern Med 1998; 128: 435-442.
Troccoli K, Pollard H, 3rd, McMahon M et al. Human immunodeficiency virus counseling and testing practices among North Carolina providers. Obstet Gynecol 2002; 100: 420-427.
Kellock DJ, Rogstad KE. Attitudes to HIV testing in general practice. Int J STD AIDS 1998; 9: 263-267.
Consolidated guidelines on HIV Testing Services. 5Cs: Consent, Confidentiality, Counselling, Correct Results and Connection. World Health Organization, 2015. URL https://www.ncbi.nlm.nih.gov/books/NBK316021/pdf/Bookshelf_NBK316021.pdf (last accessed: 8 October 2020).
Cohan D, Gomez E, Greenberg M et al. Patient perspectives with abbreviated versus standard pre-test HIV counseling in the prenatal setting: a randomized-controlled, non-inferiority trial. PLoS One 2009; 4: e5166.
Guidance on provider-initiated HIV testing and counselling in health facilities. World Health Organization, 2007. URL https://apps.who.int/iris/bitstream/handle/10665/43688/9789241595568_eng.pdf;jsessionid=356248E2A15E9A32452BC7C1DEE7A10A?sequence=1 (last accessed: 8 October 2020).
Charu L, Zetola NM, Klausner JD et al. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA 2007; 297: 1061-1062.
Bayer R, Philbin M, Remien RH. The end of written informed consent for HIV testing: not with a bang but a whimper. Am J Public Health 2017; 107: 1259-1265.
Ehrenkranz PD, Pagán JA, Begier EM et al. Written informed-consent statutes and HIV testing. Am J Prev Med 2009; 37: 57-63.
Wing C. Effects of written informed consent requirements on HIV testing rates: evidence from a natural experiment. Am J Public Health 2009; 99: 1087-1092.
Zetola NM, Grijalva CG, Gertler S et al. Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One 2008; 3: e2591.
Brewster MF. HIV exceptionalism must end. BMJ 2007; 335: 27.
Sokol DK. Commentary on ethics of HIV testing in general practice without informed consent: a case series. J Med Ethics 2005; 31: 701-702.
Rogstad K, Bramham L, Lowbury R et al. The use of a leaflet to replace verbal pretest discussion for HIV: effects and acceptability. Sex Transm Infect 2003; 79: 243-245.
Calderon Y, Haughey M, Bijur PE et al. An educational HIV pretest counseling video program for off-hours testing in the emergency department. Ann Emerg Med 2006; 48: 21-27.
Merchant RC, Clark MA, Mayer KH et al. Video as an effective method to deliver pretest information for rapid human immunodeficiency testing. Acad Emerg Med 2009; 16: 124-135.
Nastouli E, Atkins M, Seery P et al. False positive HIV antibody results with ultrasensitive serological assays in uninfected infants born to mothers with HIV. AIDS 2007; 21: 1222-1223.
Patterson SE, Milloy MJ, Ogilvie G et al. The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence. J Int AIDS Soc 2015; 18: 20572.
Kesler MA, Kaul R, Loutfy M et al. Prosecution of non-disclosure of HIV status: potential impact on HIV testing and transmission among HIV-negative men who have sex with men. PLoS One 2018; 13: e0193269.
O'Byrne P, Willmore J, Bryan A et al. Nondisclosure prosecutions and population health outcomes: examining HIV testing, HIV diagnoses, and the attitudes of men who have sex with men following nondisclosure prosecution media releases in Ottawa, Canada. BMC Public Health 2013; 13: 94.
Johnson CC, Kennedy C, Fonner V et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc 2017; 20: 21594.
Guidelines for Using HIV Testing Technologies in Surveillance. UNAIDS/WHO Working Group on HIV/AIDS/STI Surveillance, 2009. https://www.ncbi.nlm.nih.gov/books/NBK305270/pdf/Bookshelf_NBK305270.pdf (last accessed: 8 October 2020).
Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-1879.
Powers KA, Ghani AC, Miller WC et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011; 378: 256-268.
Parry JV, Mortimer PP, Perry KR et al. Towards errorfree HIV diagnosis: guidelines on laboratory practice. Commun Dis Public Health 2003; 6: 334-350.
Perry KR, Ramskill S, Eglin R et al. Improvement in the performance of HIV screening kits. Transfus Med 2008; 18: 228-240.
Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations, 2014. URL http://stacks.cdc.gov/view/cdc/23447. Published June 27, 2014. (last accessed: 8 October 2020).
Hurt CB, Nelson JAE, Hightow-Weidman LB et al. Selecting an HIV test: a narrative review for clinicians and researchers. Sex Transm Dis 2017; 44: 739-746.
Rich JD, Merriman NA, Mylonakis E et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999; 130: 37-39.
Sherman GG, Cooper PA, Coovadia AH et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J 2005; 24: 993-997.
Marinovich A, Narlieva M, Bashir M et al. False-positive result from a Bayer Versant human immunodeficiency virus type 1 branched-DNA viral load assay, with a possible role for light leakage after inadequate maintenance of the analyzer. J Clin Microbiol 2006; 4: 4288-4289.
Donnell D, Ramos E, Celum C et al. The effect of oral pre-exposure prophylaxis on the progression of HIV-1 seroconversion. AIDS 2017; 31: 2007-2016.
Zucker J, Carnevale C, Rai AJ et al. Positive or not, that is the question: HIV testing for individuals on pre-exposure prophylaxis (PrEP). J Acquir Immune Defic Syndr 2018; 78: e11-e13.
Joint United Nations Programme on HIV/AIDS (UNAIDS)-WHO. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72: 81-88.
Pillay D, Geretti AM, Weiss R. HIV. In Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, P Mortimer, eds. Principles and Practice of Clinical Virology, 6th edn, John Wiley & Sons, Ltd, West Sussex, UK, 2008.
Terzi R, Niero F, Iemoli E et al. Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion. AIDS 2007; 21: 262-263.
Hecht FM, Busch MP, Rawal B et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16: 1119-1129.
Clerca O, Cavassinia M, Bönic J et al. Prolonged seroconversion in an elite controller of HIV-1 infection. J Clin Virol 2009; 46: 371-373.
World Health Organization. Rapid HIV Tests: Guidelines for Use in HIV Testing and Counselling Services in Resource-Constrained Settings, 2004. URL http://www.emro.who.int/aiecf/web28.pdf (last accessed: 8 October 2020).
Greenwald JL, Burstein GR, Pincus J et al. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006; 8: 125-131.
Wesolowski LG, MacKellar DA, Facente SN et al. Postmarketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006; 20: 1661-1666.
Ananworanich J, Fletcher JL, Pinyakorn S et al. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology 2013; 10: 56.
Taylor D, Durigon M, Davis H et al. Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling. Int J STD AIDS 2015; 26: 215-224.
Delaney KP, Hanson DL, Masciotra S et al. Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure. Clin Infect Dis 2017; 64: 53-59.
Lindback S, Thorstensson R, Karlsson AC et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000; 14: 2333-2339.
Ridzon R, Gallagher K, Ciesielski C et al. Simultaneous transmission of human immunodeficiency virus and hepatic C virus from a needlestick injury. N Engl J Med 1997; 336: 919-922.45.
Young TN, Arens FJ, Kennedy GE et al. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev 2007; 24: CD002835.46.
Terzi R, Niero F, Lemoli E et al. Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion. AIDS 2007; 21: 262-263.
Choopanya K, Martin M, Suntharasamai P et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381: 2083-2090.
Cresswell F, Waters L, Briggs E et al. UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015. Int J STD AIDS 2016; 27: 713-738.
Mourez T, Lemée V, Delbos V et al. HIV rapid screening tests and self-tests: be aware of differences in performance and cautious of vendors. EBioMedicine 2018; 37: 382-391.
Turner SD, Anderson K, Slater M et al. Rapid point-of-care HIV testing in youth: a systematic review. J Adolesc Health 2013; 53: 683-691.
Op de Coul EL, Hahne S, van Weert YW et al. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis 2011; 11: 185.
Bulman J, Goode D, Evans A. P203 HIV-testing African service users within a newly integrated sexual health service-our experience. Sex Transm Infect 2016; 92(Suppl 1): A87.
Taegtmeyer M, MacPherson P, Jones K et al. Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme. PLoS One 2011; 6: e28019.
Wouters K, Fransen K, Beelaert G et al. Use of rapid HIV testing in a low threshold centre in Antwerp, Belgium, 2007-2012. Int J STD AIDS 2014; 25: 936-942.
Schreuder I, van der Sande MAB, de Wit M et al. Seroprevalence of H I V, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the Netherlands. Harm Reduct J 2010; 7: 25.
Fernandez-Lopez L, Folch C, Majo X et al. Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study. AIDS Care 2016; 28: 712-726.
Kendrick SR, Kroc KA, Withum D et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr 2005; 38: 142-146.
Kendrick SR, Kroc KA, Couture E et al. Comparison of point-of-care rapid HIV testing in three clinical venues. AIDS 2004; 18: 2199-2212.
Centers for Disease Control and Prevention. Quality Assurance Guidelines for Testing Using Rapid HIV Antibody Tests Waived Under the Clinical Laboratory Improvement Amendments of 1988. URL https://www.cdc.gov/mmwr/preview/mmwrhtml/00016177.htm (last accessed: 8 October 2020).
Chetty V, Moodley D, Chuturgoon A. Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. J Clin Virol 2012; 54: 180-184.
Faraoni S, Rocchetti A, Gotta F et al. Evaluation of a rapid antigen and antibody combination test in acute HIV infection. J Clin Virol 2013; 57: 84-87.
Brauer M, De Villiers JC, Mayaphi SH. Evaluation of the determinetm fourth generation HIV rapid assay. J Virol Methods 2013; 189: 180-183.
Curlin ME, Gvetadze R, Leelawiwat W et al. Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies. Clin Infect Dis 2017; 64: 1663-1669.
Conway DP, Holt M, McNulty A et al. Multi-centre evaluation of the determine HIV combo assay when used for point of care testing in a high risk clinic-based population. PLoS One 2014; 9: e94062.
Duong YT, Mavengere Y, Patel H et al. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. J Clin Microbiol 2014; 52: 3743-3748.
Laperche S, Leballais L, Ly TD et al. Failures in the detection of HIV p24 antigen with the determine HIV-1/2 Ag/Ab combo rapid test. J Infect Dis 2012; 206: 1946-1947.
Rosenberg NE, Kamanga G, Phiri S et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J Infect Dis 2012; 205: 528-534.
Masciotra S, Luo W, Westheimer E et al. Performance evaluation of the FDA-approved determine HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens. J Clin Virol 2017; 91: 95-100.
Fitzgerald N, Cross M, O’Shea S et al. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24. Sex Transm Infect 2017; 93: 100-101.
Chavez PR, Bradley HM, Wesolowski LG et al. Performance evaluation of four point-of-care HIV tests using unprocessed specimens. J Clin Virol 2020; 124: 104282.
Vázquez-Morón S, Ryan P, Ardizone-Jiménez B et al. Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting. Sci Rep 2018; 8: 1858.
Page M, Atabani SF, Wood M et al. Dried blood spot and mini-tube blood sample collection kits for postal HIV testing services: a comparative review of successes in a real-world setting. Sex Transm Infect 2019; 95: 43-45.
Pavie J, Rachline A, Loze B et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010; 5: e11581.
Pilcher CD, Louie B, Facente S et al. Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One 2013; 8: e80629.
Stekler JD, O’Neal JD, Lane A et al. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol 2013; 58(Suppl 1): e119-122.
AgutuI CA, Ngetsa CJ, Price MA et al. Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care. PLoS One 2019; 14: e0218369.
Delaugerre C, Antoni G, Mahjoub N et al. Assessment of HIV screening tests for use in preexposure prophylaxis programs. J Infect Dis 2017; 216: 382-386.
Gillespie R. Testing history and risk behaviour of individuals requesting an HIV test through an online self-sampling service. International AIDS Conference. Melbourne, Vic., Australia, July 2014. Abstract WEAX0105LB.
Centers for Disease Control and Prevention. Implementing HIV Testing in Nonclinical Settings, 2019. URL https://www.cdc.gov/hiv/pdf/testing/CDC_HIV_Implementing_HIV_Testing_in_Nonclinical_Settings.pdf (last accessed: 8 October 2020).
Greaves L, Symonds M, Saunders J et al. Is offering STI & HIV self-sampling kits to men who have sex with men (MSM) in a London sauna a feasible and acceptable way to widen access to testing? HIV Med 2014; 15: 102-103.
Guerra L, Logan L, Alston T et al. The national HIV self-sampling service. Sex Transm Infect 2016; 92: A14.
Brady M, Carpenter G, Bard B. Self-testing for HIV: Initial experience of the UK's first kit. HIV Med 2016; 17: 9.
de la Fuente L, Rosales-Statkus ME, Hoyos J et al. Are participants in a street-based HIV testing program able to perform their own rapid test and interpret the results? PLoS One 2012; 7: e46555.
Gibson W, Challenor R, Warwick Z. HIV home/self-testing: a pilot project and service evaluation. Sex Transm Infect 2016; 92: A32.
Prazuck T, Karon S, Gubavu C et al. A finger-stick whole-blood HIV self-test as an HIV screening tool adapted to the general public. PLoS One 2016; 11: e0146755.
Witzel TC, Rodger AJ, Burns FM et al. HIV self-testing among men who have sex with men (MSM) in the UK: a qualitative study of barriers and facilitators, intervention preferences and perceived impacts. PLoS One 2016; 11: e0162713.
Croxford S, Tavoschi L, Sullivan AK et al. HIV testing strategies outside of health care settings in theEuropean Union (EU)/European Economic Area (EEA): asystematic review to inform European Centre for Disease Prevention and Control guidance. HIV Med 2019; 3: 142-162.
Ahmed-Little Y, Bothra V, Cordwell D et al. Attitudes towards HIV testing via home-sampling kits ordered online (RUClear pilots 2011-12). J Public Health 2016; 38: 585-590.
Brady M, Nardone A, Buenaventura E et al. Acceptability of home HIV sampling and testing: a user survey. HIV Med 2014; 15: 89-90.
Platteau T, Fransen K, Apers L et al. Swab2know: An HIV-testing strategy using oral fluid samples and online communication of test results for men who have sex with men in Belgium. J Med Internet Res 2015; 17: e213.
Williams S, Scholfield C, Nadarzynski T et al. Acceptability, uptake and impact of online home-sampling for stis in Hampshire, UK: a service evaluation. Sex Transm Infect 2017; 93: A6.
Wayal S, Llewellyn C, Smith H et al. Home sampling kits for sexually transmitted infections: preferences and concerns of men who have sex with men. Cult Health Sex 2011; 13: 343-353.
Elliot E, Rossi M, McCormack S et al. Identifying undiagnosed HIV in men who have sex with men (MSM) by offering HIV home sampling via online gay social media: a service evaluation. Sex Transm Infect 2016; 92: 470-473.
Croxford SE, Yin Z, Burns F et al. Linkage to HIV care following diagnosis in the WHO european region: a systematic review and meta-analysis, 2006-2017. PLoS One 2018; 13: e0192403.
Pittaway H, Barnard S, Wilson E et al. SH:24-user perspectives on an online sexual health service. Sex Transm Infect 2016; 92: A19-A20.
Greacen T, Friboulet D, Fugon L et al. Access to and use of unauthorised online HIV self-tests by internet-using French-speaking men who have sex with men. Sex Transm Infect 2012; 88: 368-374.
The Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017; 4: e349-356.
Fowler MG, Lampe MA, Jamieson DJ et al. Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol 2007; 197: S3-S9.
Suksomboon N, Poolsup N, Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J Clin Pharm Ther 2007; 32: 293-311.
Flagg EW, Weinstock HS, Frazier EL et al. Bacterial sexually transmitted infections among HIV-infected patients in the United States: estimates from the Medical Monitoring Project. Sex Transm Dis 2015; 42: 171-179.
Dean BB, Scott M, Hart R et al. Sexually transmitted disease testing of human immunodeficiency virus-infected men who have sex with men: room for improvement. Sex Transm Dis 2017; 44: 678-684.
Sarah D, Evans BG, Elford J. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis 2007; 34: 783-790.
Landes M, Thorne C, Barlow P et al. Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol 2007; 22: 925-936.
Tiplica GS, Radcliffe K, Evans C et al. 2015 European guidelines for the management of partners of persons with sexually transmitted infections. J Eur Acad Dermatol Venereol 2015; 29: 1251-1257.